1. Home
  2. PHVS vs UTL Comparison

PHVS vs UTL Comparison

Compare PHVS & UTL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PHVS
  • UTL
  • Stock Information
  • Founded
  • PHVS 2015
  • UTL 1984
  • Country
  • PHVS Netherlands
  • UTL United States
  • Employees
  • PHVS N/A
  • UTL N/A
  • Industry
  • PHVS Biotechnology: Pharmaceutical Preparations
  • UTL Power Generation
  • Sector
  • PHVS Health Care
  • UTL Utilities
  • Exchange
  • PHVS Nasdaq
  • UTL Nasdaq
  • Market Cap
  • PHVS 1.0B
  • UTL 939.3M
  • IPO Year
  • PHVS 2021
  • UTL N/A
  • Fundamental
  • Price
  • PHVS $21.25
  • UTL $60.26
  • Analyst Decision
  • PHVS Buy
  • UTL
  • Analyst Count
  • PHVS 6
  • UTL 0
  • Target Price
  • PHVS $35.67
  • UTL N/A
  • AVG Volume (30 Days)
  • PHVS 95.8K
  • UTL 53.3K
  • Earning Date
  • PHVS 11-15-2024
  • UTL 11-04-2024
  • Dividend Yield
  • PHVS N/A
  • UTL 2.82%
  • EPS Growth
  • PHVS N/A
  • UTL 5.48
  • EPS
  • PHVS N/A
  • UTL 2.92
  • Revenue
  • PHVS N/A
  • UTL $496,900,000.00
  • Revenue This Year
  • PHVS N/A
  • UTL $0.88
  • Revenue Next Year
  • PHVS N/A
  • UTL $6.64
  • P/E Ratio
  • PHVS N/A
  • UTL $20.51
  • Revenue Growth
  • PHVS N/A
  • UTL N/A
  • 52 Week Low
  • PHVS $15.00
  • UTL $45.26
  • 52 Week High
  • PHVS $33.00
  • UTL $63.52
  • Technical
  • Relative Strength Index (RSI)
  • PHVS 46.38
  • UTL 55.70
  • Support Level
  • PHVS $22.86
  • UTL $57.77
  • Resistance Level
  • PHVS $25.40
  • UTL $61.51
  • Average True Range (ATR)
  • PHVS 1.56
  • UTL 1.65
  • MACD
  • PHVS -0.28
  • UTL 0.25
  • Stochastic Oscillator
  • PHVS 1.16
  • UTL 83.68

About PHVS Pharvaris N.V.

Pharvaris NV is a clinical-stage company. It is focused on the discovery and development and commercialization of therapies for rare diseases with significant unmet need, initially focused on angioedema and other bradykinin-mediated diseases. The company's activities are considered to be one segment which comprises the discovery, development and commercialization of oral bradykinin-B2-receptor antagonists .

About UTL UNITIL Corporation

Unitil Corp is a holding company, through its subsidiaries it is engaged in the local distribution of electricity and natural gas throughout its service territories in the states of New Hampshire, Massachusetts, and Maine. It reports three segments namely utility gas operations, utility electric operations, and non-regulated.

Share on Social Networks: